SEHK:9969Biotechs
InnoCare Pharma (SEHK:9969) Could Be 24% Undervalued Following Profit Turn
InnoCare Pharma (SEHK:9969) stock is in focus after the company reported a shift from loss to profit in the first half of 2026 and issued guidance to remain profitable for the full year.
The recent earnings swing to profit and guidance for higher EPS in the second half appear to have supported InnoCare Pharma’s share price, which has a 90 day share price return of 27.52% and a year to date share price return of 18.64%, against a 1 year total shareholder return that is down 12.04%.
Compare...